Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by canadapieton Apr 27, 2023 11:21am
65 Views
Post# 35417048

RE:RE:RE:RE:RE:Nothing like some 'leaks' on the FDA Resubmission

RE:RE:RE:RE:RE:Nothing like some 'leaks' on the FDA Resubmission
What an investment change, really "bizar", from a 1 B dollar projection to the pink sheets........!!!!!
Hilarious! 




RE:RE:RE:RE:Nothing like some 'leaks' on the FDA Resubmission
While I am all for getting THTX to close above $1 per share for 10 consecutive trading days to take the potential for delisting from NASDAQ off the table, it would hardly be a disaster if it happened. Also, it is unlikey to happen until February 2024 if they fail to get the stock price higher. But the reason it would not be a disaster is it traded on the pink sheets for many years without any issues prior to being listed on NASDAQ.  Now, I really don't want it to trade on the pink sheets again, as there are worthwhile advantages to owners of THTX if it is on NASDAQ, but it would not be a total disaster if it did.
Trogarzon wrote:Just get the dam thing above 1$ to avoid consolidation disaster.
 

<< Previous
Bullboard Posts
Next >>